Palma, David A.
Salama, Joseph K.
Lo, Simon S.
Senan, Suresh
Treasure, Tom
Govindan, Ramaswamy
Weichselbaum, Ralph
Article History
First Online: 24 June 2014
Competing interests
: S.S. declares he receives honouraria and has a research agreement with Varian Medical Systems. He is also a member of trial management committee (with expenses reimbursed) for Lilly Oncology. R.G. is a consultant for Abbott Oncology, Boehringer-Ingelheim, Bristol–Meyers Squibb, Covidien, Genentech, Merck, Pfizer and Roche. R.W. is an advisory board member of Catherex, Inc., a consultant for Bristol–Meyers Squib and RefleXion Pharmaceuticals, and has received a grant and stocks from Reata. The other authors declare no competing interests.